{"id":"https://openalex.org/W4413810366","doi":"https://doi.org/10.1016/s2152-2650(25)02240-2","title":"ABCL-261: Repercussions of COVID-19 Infection on Evolution of Non-Hodgkin Lymphomas","display_name":"ABCL-261: Repercussions of COVID-19 Infection on Evolution of Non-Hodgkin Lymphomas","publication_year":2025,"publication_date":"2025-08-28","ids":{"openalex":"https://openalex.org/W4413810366","doi":"https://doi.org/10.1016/s2152-2650(25)02240-2"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(25)02240-2","doi":"https://doi.org/10.1016/s2152-2650(25)02240-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(25)02240-2","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029259350","display_name":"Vasile Musteata","orcid":"https://orcid.org/0000-0002-9471-7170","observed_orcids":["https://orcid.org/0000-0002-9471-7170"]},"institutions":[{"id":"https://openalex.org/I4210124354","display_name":"Nicolae Testemi\u021banu State University of Medicine and Pharmacy","ror":"https://ror.org/03xww6m08","country_code":"MD","type":"education","lineage":["https://openalex.org/I4210124354"]}],"countries":["MD"],"is_corresponding":false,"raw_author_name":"Vasile Musteata","raw_affiliation_strings":["N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova","institution_ids":["https://openalex.org/I4210124354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119469977","display_name":"Valeria Muntean","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124354","display_name":"Nicolae Testemi\u021banu State University of Medicine and Pharmacy","ror":"https://ror.org/03xww6m08","country_code":"MD","type":"education","lineage":["https://openalex.org/I4210124354"]}],"countries":["MD"],"is_corresponding":false,"raw_author_name":"Valeria Muntean","raw_affiliation_strings":["N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova","institution_ids":["https://openalex.org/I4210124354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057593538","display_name":"Larisa Mustea\u0163\u0103","orcid":"https://orcid.org/0000-0001-7162-6391","observed_orcids":["https://orcid.org/0000-0001-7162-6391"]},"institutions":[{"id":"https://openalex.org/I4210124354","display_name":"Nicolae Testemi\u021banu State University of Medicine and Pharmacy","ror":"https://ror.org/03xww6m08","country_code":"MD","type":"education","lineage":["https://openalex.org/I4210124354"]}],"countries":["MD"],"is_corresponding":false,"raw_author_name":"Larisa Musteata","raw_affiliation_strings":["N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova","institution_ids":["https://openalex.org/I4210124354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049306513","display_name":"Dumitrita Urescu","orcid":"https://orcid.org/0000-0002-6711-0402","observed_orcids":["https://orcid.org/0000-0002-6711-0402"]},"institutions":[{"id":"https://openalex.org/I4210108897","display_name":"Institutul Oncologic din Republica Moldova","ror":"https://ror.org/01m92rg76","country_code":"MD","type":"healthcare","lineage":["https://openalex.org/I4210108897"]}],"countries":["MD"],"is_corresponding":false,"raw_author_name":"Dumitrita Urescu","raw_affiliation_strings":["Institute of Oncology, Chisinau, Republic of Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology, Chisinau, Republic of Moldova","institution_ids":["https://openalex.org/I4210108897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023380541","display_name":"Nina Sghibneva-Bobeico","orcid":"https://orcid.org/0000-0001-7980-5183","observed_orcids":["https://orcid.org/0000-0001-7980-5183"]},"institutions":[{"id":"https://openalex.org/I4210108897","display_name":"Institutul Oncologic din Republica Moldova","ror":"https://ror.org/01m92rg76","country_code":"MD","type":"healthcare","lineage":["https://openalex.org/I4210108897"]}],"countries":["MD"],"is_corresponding":false,"raw_author_name":"Nina Sghibneva-Bobeico","raw_affiliation_strings":["Institute of Oncology, Chisinau, Republic of Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology, Chisinau, Republic of Moldova","institution_ids":["https://openalex.org/I4210108897"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106741017","display_name":"Irina Cebanu","orcid":"https://orcid.org/0009-0000-8980-5988","observed_orcids":["https://orcid.org/0009-0000-8980-5988"]},"institutions":[{"id":"https://openalex.org/I4210108897","display_name":"Institutul Oncologic din Republica Moldova","ror":"https://ror.org/01m92rg76","country_code":"MD","type":"healthcare","lineage":["https://openalex.org/I4210108897"]}],"countries":["MD"],"is_corresponding":false,"raw_author_name":"Irina Cebanu","raw_affiliation_strings":["Institute of Oncology, Chisinau, Republic of Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology, Chisinau, Republic of Moldova","institution_ids":["https://openalex.org/I4210108897"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":null,"first_page":"S726","last_page":"S727"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.18140000104904175,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.024800000712275505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9599999785423279},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9430000185966492},{"id":"https://openalex.org/keywords/lymphoma-progression","display_name":"lymphoma progression","score":0.6959999799728394},{"id":"https://openalex.org/keywords/aggressive-lymphoma","display_name":"aggressive lymphoma","score":0.6269999742507935},{"id":"https://openalex.org/keywords/indolent-lymphoma","display_name":"indolent lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemotherapy-discontinuation","display_name":"chemotherapy discontinuation","score":0.5950000286102295},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.4300000071525574},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5270000100135803},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7540000081062317},{"id":"https://openalex.org/keywords/viral-pneumonia","display_name":"viral pneumonia","score":0.5860000252723694},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.4819999933242798},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9305828809738159},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7834176421165466},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5156325101852417},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5150299072265625},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4703281819820404},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.4434782564640045},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.26912224292755127},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.268045574426651},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2545989155769348},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08095285296440125},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.07269078493118286},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.05079689621925354}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(25)02240-2","doi":"https://doi.org/10.1016/s2152-2650(25)02240-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(25)02240-2","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400455102","https://openalex.org/W4403499224","https://openalex.org/W4283400506","https://openalex.org/W3176547226","https://openalex.org/W4382204443","https://openalex.org/W3097271251","https://openalex.org/W4385655708","https://openalex.org/W7038373384","https://openalex.org/W3193015544","https://openalex.org/W3096074657"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-10T00:00:00"}